Optimus Oncology Profile
Key Indicators
- Authorised Capital ₹ 14.95 Cr
as on 16-11-2024
- Paid Up Capital ₹ 14.01 Cr
as on 16-11-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.87 Cr
as on 16-11-2024
- Revenue 9.19%
(FY 2023)
- Profit 724.44%
(FY 2023)
- Ebitda 1.99%
(FY 2023)
- Net Worth 8.99%
(FY 2023)
- Total Assets -3.37%
(FY 2023)
About Optimus Oncology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.95 Cr and a paid-up capital of Rs 14.01 Cr.
The company currently has active open charges totaling ₹20.87 Cr.
The Key Managerial Personnel (KMP) at Optimus Oncology Private Limited India is Renuka Buwa as COMPANY SECRETARY. Akshayanath Sharma, Bhushan Nemade, Manish Siddha, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC285794
- Company No.
285794
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Optimus Oncology?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhushan Nemade  | Managing Director | 12-Sep-2016 | Current |
| Renuka Buwa | Company Secretary | 10-Apr-2023 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pramod Tike | Director | 12-Sep-2016 | Current |
| Nikhil Ghadyalpatil | Director | 12-Sep-2016 | Current |
| Manish Siddha | Director | 12-Sep-2016 | Current |
| Debnarayan Dutta | Director | 12-Sep-2016 | Current |
| Chilukuri Srinivas | Director | 12-Sep-2016 | Current |
| Akshayanath Sharma | Nominee Director | 14-Sep-2019 | Current |
Financial of Optimus Oncology.
Optimus Oncology Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.19% increase. The company also saw a substantial improvement in profitability, with a 724.44% increase in profit. The company's net worth moved up by a moderate rise of 8.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Optimus Oncology?
In 2023, Optimus Oncology had a promoter holding of 89.81% and a public holding of 10.19%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sankalp Speciality Healthcare Private LimitedActive 11 years 4 monthsBhushan Nemade is a mutual person
- Optimus Healthcare & Research Private LimitedActive 8 years 1 month
Bhushan Nemade is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jan 2022 | ₹8.70 M | Open |
New India Co-Op Bank Limited Creation Date: 19 Sep 2019 | ₹13.00 Cr | Open |
Others Creation Date: 29 Aug 2017 | ₹7.00 Cr | Open |
How Many Employees Work at Optimus Oncology?
Unlock and access historical data on people associated with Optimus Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Optimus Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optimus Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
